Načítá se...
Optimal Duration of Treatment for HCV Genotype 1 Infection in Slow Responders: A Meta-Analysis
BACKGROUND: A head-to-head comparison of the 72-week and 48-week anti-HCV therapies in slow responders with genotype 1 infection has been performed in several randomized clinical trials (RCTs). OBJECTIVES: This review aimed at summarizing and pooling the results of these studies. MATERIALS AND METHO...
Uloženo v:
| Hlavní autoři: | , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Kowsar
2011
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3227488/ https://ncbi.nlm.nih.gov/pubmed/22140384 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5812/kowsar.1735143X.721 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|